1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
11/16/2023 | PETS | Buy Now | PetMed Express | $4.76 | 36.55% | Morgan Stanley | Erin Wright | $7 → $6.5 | Maintains | Underweight | Get Alert |
10/31/2023 | PETS | Buy Now | PetMed Express | $4.76 | 47.06% | Morgan Stanley | Erin Wright | $10 → $7 | Maintains | Underweight | Get Alert |
10/19/2023 | PETS | Buy Now | PetMed Express | $4.76 | 110.08% | Morgan Stanley | Erin Wright | $17 → $10 | Maintains | Underweight | Get Alert |
07/27/2023 | PETS | Buy Now | PetMed Express | $4.76 | 257.14% | Morgan Stanley | Erin Wright | $17 → $17 | Reiterates | Underweight → Underweight | Get Alert |
05/25/2023 | PETS | Buy Now | PetMed Express | $4.76 | 320.17% | Lake Street | Ryan Meyers | → $20 | Initiates | → Buy | Get Alert |
03/23/2023 | PETS | Buy Now | PetMed Express | $4.76 | 257.14% | Morgan Stanley | Erin Wright | $18 → $17 | Maintains | Underweight | Get Alert |
11/08/2022 | PETS | Buy Now | PetMed Express | $4.76 | 278.15% | Morgan Stanley | Erin Wright | $19 → $18 | Maintains | Underweight | Get Alert |
07/26/2022 | PETS | Buy Now | PetMed Express | $4.76 | 299.16% | Morgan Stanley | Erin Wright | $20 → $19 | Maintains | Underweight | Get Alert |
05/10/2022 | PETS | Buy Now | PetMed Express | $4.76 | 320.17% | Morgan Stanley | Erin Wright | $21 → $20 | Maintains | Underweight | Get Alert |
01/25/2022 | PETS | Buy Now | PetMed Express | $4.76 | 341.18% | Morgan Stanley | Erin Wright | $25 → $21 | Maintains | Underweight | Get Alert |
01/20/2022 | PETS | Buy Now | PetMed Express | $4.76 | 572.27% | Sidoti & Co. | Anthony Lebiedzinski | → $32 | Upgrade | Neutral → Buy | Get Alert |
11/18/2021 | PETS | Buy Now | PetMed Express | $4.76 | 425.21% | Morgan Stanley | Erin Wright | — | Initiates | → Underweight | Get Alert |
10/01/2021 | PETS | Buy Now | PetMed Express | $4.76 | 488.24% | Jefferies | Stephanie Wissink | — | Initiates | → Hold | Get Alert |
06/03/2021 | PETS | Buy Now | PetMed Express | $4.76 | 719.33% | Sidoti & Co. | Anthony Lebiedzinski | — | Downgrade | Buy → Neutral | Get Alert |
The latest price target for PetMed Express (NASDAQ: PETS) was reported by Morgan Stanley on November 16, 2023. The analyst firm set a price target for $6.50 expecting PETS to rise to within 12 months (a possible 36.55% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for PetMed Express (NASDAQ: PETS) was provided by Morgan Stanley, and PetMed Express maintained their underweight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PetMed Express, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PetMed Express was filed on November 16, 2023 so you should expect the next rating to be made available sometime around November 16, 2024.
While ratings are subjective and will change, the latest PetMed Express (PETS) rating was a maintained with a price target of $7.00 to $6.50. The current price PetMed Express (PETS) is trading at is $4.76, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.